TransMedics (TMDX) Cash & Current Investments (2018 - 2026)
TransMedics has reported Cash & Current Investments over the past 8 years, most recently at $488.4 million for Q4 2025.
- For Q4 2025, Cash & Current Investments rose 45.08% year-over-year to $488.4 million; the TTM value through Dec 2025 reached $488.4 million, up 45.08%, while the annual FY2025 figure was $488.4 million, 45.08% up from the prior year.
- Cash & Current Investments for Q4 2025 was $488.4 million at TransMedics, up from $466.2 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $488.4 million in Q4 2025 and troughed at $58.1 million in Q2 2022.
- A 5-year average of $268.2 million and a median of $320.1 million in 2024 define the central range for Cash & Current Investments.
- Biggest five-year swings in Cash & Current Investments: surged 119.44% in 2021 and later crashed 48.26% in 2022.
- Year by year, Cash & Current Investments stood at $92.5 million in 2021, then soared by 117.61% to $201.2 million in 2022, then skyrocketed by 96.25% to $394.8 million in 2023, then decreased by 14.73% to $336.6 million in 2024, then soared by 45.08% to $488.4 million in 2025.
- Business Quant data shows Cash & Current Investments for TMDX at $488.4 million in Q4 2025, $466.2 million in Q3 2025, and $400.6 million in Q2 2025.